Test of PyL PET/CT for high-risk or returning prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This Phase 2 study checks how well a scan called PyL PET/CT can help find prostate cancer that is high-risk or has come back by blood test. The goal is to improve how doctors detect spread and guide the next treatment steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male and age 18 or older
- You have confirmed prostate cancer (adenocarcinoma) on pathology/biopsy
- You fit one group: high-risk cancer OR prostate cancer relapse by PSA blood tests
- Your recent scans must show no cancer spread on standard scans (CT chest/abdomen/pelvis and a bone scan) within 3 months
- You must be able to have a PET/CT scan (scanner may not fit people over about 450 pounds)
- Your treatment should not have changed after the standard-of-care imaging you had
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how a special PET/CT scan (using 18F-DCFPyL) helps evaluate prostate cancer that is either high-risk at diagnosis or has come back based on PSA blood tests. It may help your care team better stage (map) the cancer and guide next steps.
This observational study follows men with prostate cancer who get a specific PET scan (PYLARIFY) to see how well it identifies cancer spread or recurrence. It may help doctors better understand where the cancer is so treatment decisions can be improved.
This study follows people with prostate cancer whose PSA blood test has risen again after standard treatment. It uses an approved PET scan tracer to look for cancer spread, which may help doctors understand how the disease is progressing.
This study tests a new type of PET scan (a detailed imaging test) to find out if prostate cancer has come back after treatment. You'll receive an injection of a special tracer and then have a scan that takes pictures to help doctors locate any cancer.
This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.
This early-phase study tests a precise, targeted radiation treatment for prostate cancer, using a special PET scan to help plan exactly where to treat. It may help reduce the amount of radiation to surrounding tissues while treating the cancer.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.